Biotech China 2014

Oncology: Duke University

Total Score People Score Events Score
76 58 30
Date Event Presentation Speakers
September 12, 2013 The 2nd International Conference on Genomics in the Americas De novo Mutations in Autism Spectrum Disorders Revealed by Whole Genome Sequencing Yong-hui Jiang
May 31, 2013 ASCO Annual Meeting 2013 Thrombosis and Cancer: Emerging Data for the Practicing Oncologist Gary H. Lyman
Treatment of Patients with Locally Advanced Rectal Cancer and Liver Metastases (C03) Brian G. Czito
Special Session David Harpole
Education Sessions H Kim Lyerly
Educations Sessions David Rizzieri
April 6, 2013 AACR Annual Meetings The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Jeremy N. Rich
September 13, 2012 International Society of Gastrointestinal Oncology Session 4 | Hot Topics in Gastrointestinal Oncology Christopher Willett
Case Presentations/Panel Discussion | Case 1: Rectal Cancer with Resectable Liver Metastases Brian G. Czito
May 18, 2011 SBI 10th Postgraduate Course Updates in Imaging | Nuclear Medicine in Breast Imaging Jay A. Baker
April 29, 2011 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies SESSION 2 | Welcome and Introductions Patrick Buckley
Simultaneous Session 2 | Practical Hematopathology | Cells, Chromosomes, and Molecules in AML—Providing Insights Into Classification, Diagnosis, and Prognosis Patrick Buckley
Session 1 | Management of Diabetes in the Oncology Patient Angela Johns
SESSION 2 | Recurrent Molecular Mutations in Acute Myeloid Leukemia Michael B. Datto
SESSION 2 | Determining Immunophenotype in Acute Myeloid Leukemia | At Diagnosis and Beyond Anand Shreeram Lagoo
SESSION 2 | Current Classification of Acute Myeloid Leukemia | Implications of Dysplastic Changes and Cytogenetic and Molecular Abnormalities Patrick Buckley
Debate | Therapy for secondary leukemia in the “robust” elderly patient Arati Rao
Personalizing Health Care Through Genomic Profiling Sandeep S. Dave
Debate | Induction therapy for patients with acute lymphoblastic leukemia should contain asparaginase. Mitchell Horwitz
Debate | Options for chronic myeloid leukemia induction therapy | the choice for a new generation? Joseph Moore
Welcome and Presession Survey Joseph Moore
Leukemia Session Joseph Moore
New Options in Hodgkin Lymphoma Anne W. Beaven
The Future of Chronic Lymphocytic Leukemia Therapy Mark C. Lanasa
Debate | Bendamustine | rituximab is the standard of care for induction therapy of follicular lymphoma. Anne W. Beaven
Welcome and Presession Survey Anne W. Beaven
Lymphoma Session Anne W. Beaven
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Combinatorial mRNA Control Jack Keene
Session XI: Aptamers Bruce A. Sullenger
Using Nucleic Acid Binding Polymers to Control Aptamers and Inflammation Bruce A. Sullenger
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities Disparities in screening and primary treatment for prostate cancer Stephen J. Freedland
American College of Surgeons Oncology Group and cancer health disparities in clinical trials David M. Ota
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved Disparities in screening and primary treatment for prostate cancer Stephen J. Freedland
American College of Surgeons Oncology Group and cancer health disparities in clinical trials David M. Ota
May 4, 2010 Biomarker World Congress 2010 Evolutionary Genetics of Alzheimer’s Disease Allen D. Roses
April 30, 2010 UCSF Radiation Oncology Update: Management of Recurrent Disease Phillips Lecture: The Use of IORT for Recurrent Disease Christopher Willett
Anti-angiogenic Therapies and Radiation for GI Recurrences Christopher Willett
Overview of Hyperthermia Mark W. Dewhirst
April 9, 2010 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies The Biologic Significance of Clonal T-Cells | Session 2 Michael B. Datto
CD30-Positive and Other Cutaneous T-Cell Proliferations | Session 2 Patrick Buckley
General Principles in Treating T-Cell Lymphomas | Session 2 Anne W. Beaven
Classification of T-Cell Lymphomas | Session 2 Anand Shreeram Lagoo
Welcome, Introductions and Presession Survey | Session 2 Patrick Buckley
Simultaneous Session 2 Practical Hematopathology: T-Cell Lymphomas Patrick Buckley
Palliative and End-of-Life Care Gwynn D. Long
Pharmacy Session Tippu Khan
Transplantation Therese Hennig
Treatment Options Patricia H. Davis
Pathophysiology and Diagnosis Mark C. Lanasa
Welcome and Presession Survey Joseph Moore
Leukemia Session Joseph Moore
Interesting Cases and Postsession Survey | Session 2 Anne W. Beaven, Patrick Buckley, Anand Shreeram Lagoo
Case-Based Presentation Myeloproliferative Neoplasms: What Are We All JAKed Up About? Murat O. Arcasoy
Debate Allogeneic Transplantation Is Standard for All Patients Aged < 55 Years With AML in First Remission Who Do Not Have Good-Risk Cytogenetics Nelson J. Chao, Jon Gockerman
The Future of Personalized Therapy: The Application of Genomics and MicroRNA in Guiding Therapy Sandeep S. Dave
Debate Patients With Philadelphia Chromosome–Positive ALL: Transplant Now or Later? Gwynn D. Long
Debate Transplantation vs. Novel, Less Lethal Approaches to MDS Carlos de Castro, Mitchell Horwitz
Bone Marrow Transplantation Workshop Nelson J. Chao
Debate The Best Therapy for Elderly Patients With AML: 7+3 Is Good Enough for Me! Joseph Moore, Arati Rao
Use of New Stem Cell Mobilization Agents for Patients and Healthy Donors Mitchell Horwitz
Recent Advances in Posttransplantation Immune Modulation Following Nonablative Allogeneic Transplantation David Rizzieri
Recent Advances in Cord Blood Transplantation Nelson J. Chao
Debate Fludarabine-Based Regimens Are the Preferred First-line Approach to Patients With CLL David Rizzieri, Mark C. Lanasa
Debate Induction Therapy in Preparation for Transplantation: Immunomodulator or Proteasome Inhibitor? Cristina Gasparetto
How I Treat High-Risk DLBCL Anne W. Beaven
Keynote Address New Therapies for PNH Wendell F. Rosse
Welcome and Presession Survey David Rizzieri
Lymphoma Session Anne W. Beaven
February 19, 2010 Eighth International Symposium on Supportive Care in Oncology: Cancer Management in the Era of Targeted Agents Management of Hematologic Adverse Events Jeffrey Crawford
Consequences of Targeting Cell Surface Antigens Jeffrey Crawford
Maintaining Bone Health Jeffrey Crawford
Supportive Care Issues With Targeted Agents Jeffrey Crawford
Management of Thrombosis Victor F. Tapson
Supporting the Cardiovascular System Jeffrey Crawford
Welcome, Introductions, and Presession Survey Jeffrey Crawford
January 21, 2010 2010 DERMATOLOGY FOUNDATION CLINICAL SYMPOSIA: ADVANCES IN DERMATOLOGY Pediatric Dermatology: The Power of Intuition Neil S. Prose
Difficult Conversations: Dealing with Patient Disappointments and Medical Mistakes Neil S. Prose
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Genome-scale RNAi-based Screening to Identify Flavivirus Host Factors in Insects and Humans James L. Pearson
October 2, 2009 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine Treatment Options for MCL Louis Diehl
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers Using Proteomics and Established Patient Cohorts to Address Relevant Clinical Biomarker Needs: The MURDOCK Study J. Will Thompson
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Critical Path Meets Cardiac Safety: A Novel, Collaborative Paradigm for Cardiac Safety Evaluation Mitchell W. Krucoff
January 5, 2009 High Content Analysis High-Content Fluorescent Microscopy Imaging Approaches to Measure Rescue of Neurodegenerative Primary Neurons in a Drug Discovery Platform Oscar Joseph Trask
November 23, 2008 Advanced Technology in Radiation Oncology Efficacy And Immunologic Effects Of RNA-Pulsed Dendritic Cell Vacccines Targeting Human Cytomegalovirus Antigens In Patients With Glioblastoma. Duane Mitchell
November 21, 2008 The 13th Annual Scientific Meeting of the Society for Neuro-Oncology Phase II Study Of Bevacizumab (BVZ) Plus Irinotecan (CPT-11) In Children With Recurrent Malignant Glioma (MG) And Diffuse Brain Stem Glioma (BSG) A Pediatric Brain Tumor Consortium Study (PBTC-022). Sridharan Gururangan
September 29, 2008 Genomic Biomarkers Lost in Translation: Factors Affecting the Clinical Uptake of Molecular Diagnostics Judd Staples
Integration of Metabolic and Transcriptomic Profiling for Understanding of Diabetes and Obesity Mechanisms Christopher B. Newgard
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty H Kim Lyerly, Neil Spector, Raj K. Puri
Introduction H Kim Lyerly
Panel Discussion: Obstacles to Development--Ten Barriers to Proving Agents are Effective and Safe Kim H Lyerly
Proof of Concept to the Clinical Investigator: What are Meaningful Endpoints in Early Stage Development Neil Spector
Panel Discussion Neil Spector
Cancer Vaccines and Immunotherapy H Kim Lyerly, Raj K. Puri
May 30, 2008 ASCO Annual'08 Meeting cancer prevention/epidemiology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
geriatric oncology-- Internal Medicine for the Oncologist Harvey Jay Cohen
health services research-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
tumor biology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
March 25, 2008 Molecular Diagnostics Prospective Medicine: The Next Health Care Transformation Ralph Snyderman
An Integrated Genomic Approach for Treatment of Patients with Advanced Ovarian Cancer Holly K Dressman
March 25, 2008 Clinical Trials Asia Trials and Tribulations of Conducting Clinical Studies in India: Vasantha P Rao
March 25, 2008 CANCER MOLECULAR MARKERS An Integrated Genomic Approach for the Treatment of Patients with Advanced Stage Ovarian Cancer Holly K Dressman
November 15, 2007 2007 Fourth International Conference Keynote #1 Overview of CAM Science Ralph Snyderman
October 20, 2007 Fourth Annual Fall Oncology Conference Current Directions in Advanced Prostate Cancer Therapy Andrew J Armstrong
October 11, 2007 Sixth International Colorectal Cancer Congress Novel Combinations of VEGF/VEGFR and mTOR Inhibitors Herbert Hurwitz
How to Use Angiogenesis Inhibitors Safely: Practical Issues Herbert Hurwitz
Should Anti-VEGF Therapy Continue Beyond Progession? Herbert Hurwitz
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.